Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?25.32
 
WKN: A2AJW8 / Symbol: ADVM / Name: Adverum Bio / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Adverum Biotechnologies Inc. Stock

Adverum Biotechnologies Inc. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
With a target price of 25 € there is potential for a 1711.59% increase which would mean more than doubling the current price of 1.38 € for Adverum Biotechnologies Inc..
So far the community has only identified positive things for Adverum Biotechnologies Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Adverum Biotechnologies Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Adverum Biotechnologies Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Adverum Biotechnologies Inc. - - - - - - -
Evolus Inc -3.360% 8.824% 23.333% 70.115% 63.536% 120.896% -
Ardelyx Inc. -3.940% 7.242% 4.451% 29.696% -4.187% 390.088% 30.598%
Coherus Bioscien. 1.760% -24.782% -18.208% -79.734% -69.368% -93.792% -95.284%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Examining the financials of Adverum Bio, a company within the Biotechnology & Medical Research sector, reveals a mixed picture characterized by significant challenges. Despite the potential that the biotechnology industry offers, particularly with advancements in medical research and therapies, Adverum Bio's financial metrics indicate a period of struggle, marked by negative earnings, hefty operating losses, and a concerning trend in revenue growth. The company's market capitalization, limited revenue, and escalating expenses add to a narrative that calls for careful scrutiny.

Pros of Adverum Bio's Financials:

Strong Market Capitalization: With a market capitalization of approximately $156.71 million, Adverum Bio retains a presence in the biotechnology space. A robust market cap can attract institutional investors and lend credibility to a company within this highly volatile industry.

Comments

Prediction Buy
Perf. (%) -
Target price 36.260
Change
Ends at 14.08.25

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target lowered by analysts at Truist Financial Co. from $60.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 27.288
Change
Ends at 13.08.25

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 36.696
Change
Ends at 19.07.25

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target raised by analysts at Chardan Capital from $4.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Show more